Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background

doi:10.4330/wjc.v8.i2.120

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (20206)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

1106

WORD

454

HTML

14087

Figures (1-1)

821

Tables (1-1)

476

Sum=16944

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1300

Download

1951

Sum=3251

Feb 26, 2016 (publication date) through Feb 16, 2026

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Cardiol. Feb 26, 2016; 8(2): 120-131
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.120

Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background

Giulia Ganzetti, Anna Campanati, Elisa Molinelli, Annamaria Offidani

Giulia Ganzetti, Anna Campanati, Elisa Molinelli, Annamaria Offidani, Dermatological Unit, Department of Clinical and Molecular Sciences, Polytehnic Marche University, 60126 Ancona, Italy

Author contributions: Ganzetti G, Campanati A and Molinelli E wrote the paper; Offidani A supervised the work.

Conflict-of-interest statement: All authors declare no conflict of interest.

Correspondence to: Dr. Giulia Ganzetti, MD, PhD, Dermatological Unit, Department of Clinical and Molecular Sciences, Polytehnic Marche University, Via Conca, 71, 60126 Ancona, Italy. giulia.ganzetti@alice.it

Telephone: +39-71-5965686 Fax: +39-71-5963446

Received: April 28, 2015
Peer-review started: May 6, 2015
First decision: July 22, 2015
Revised: October 8, 2015
Accepted: December 17, 2015
Article in press: December 18, 2015
Published online: February 26, 2016
Processing time: 299 Days and 14.6 Hours

Abstract

Psoriasis is a chronic inflammatory immune-mediated skin disease, frequently associated with systemic comorbidities. According to recent data, patients with psoriasis show a greater prevalence of metabolic syndrome, which confers a higher cardiovascular risk. The link between these pathological conditions appears to be a chronic low-grade inflammatory status. The aim of this review is to focus on the multiple epidemiological and physio-pathogenetic aspects linking non-alcoholic fatty liver disease, psoriasis, and cardiovascular disease.

Keywords: Psoriasis; Non-alcoholic fatty liver disease; Cardiovascular risk

Core tip: The review focuses on recent scientific data regarding the multiple physio-pathogenetic aspects of the possible link between psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease. The multidisciplinary approach to psoriatic patients appears mandatory to treat concomitant psoriasis-related comorbidity, and the risk/benefit of both biologic and non-biologic therapies should be evaluated.